Myxoma


A myxoma is a myxoid tumor of primitive connective tissue. It is most commonly found in the heart but can also occur in other locations.

Types

MyxomaMarginVascular patternCellularityStromaStaining characteristicsRecurrence rateImage
Cutaneous myxoma or Superficial angiomyxomaPoor to moderately circumscribed, multilobularScattered thin-walled vesselsModerately cellular, bland spindled and stellate cells, variable inflammatory cell infiltrateAbundant mucin with clefts. Up to 30% have an associated epithelial componentVimentin; variable staining with CD34, factor XIIIA, SMA, MSA and S-10020–30%
Intramuscular myxomaPoorly circumscribed merges with surrounding muscleHypovascular variant; hypervascular variantHypocellular variant; hypercellular variant; bland spindle cellsAbundant mucin with cystic spaces. Hypercellular variant has strands of collagenVimentin; variable staining with actin, desmin, CD34-
Juxta-articular myxomaPoorly circumscribed infiltrates surrounding tissueFocally vascularFocally hypercellular, peripheral spindle cells with occasional atypical cells and mitosesAbundant mucin, 89% of cases contain cystic spaces lined by fibrin or collagenVimentin; variable staining with actin, desmin, CD3434%-
Aggressive angiomyxomaInfiltrativeUniformly distributed medium-sized blood vessels often with prominent hyalinizationLow to moderately cellular, evenly distributed round, spindled or stellate cellsLoose myxoid to focally collagenousVimentin, desmin, SMA, MSA, estrogen and progesterone receptor36–72%-
AngiomyofibroblastomaWell circumscribedAbundant thin-walled blood vesselsAlternating hypercellular and hypocellular areas, perivascular condensations of spindled to epithelioid stromal cellsCollagenous to edematous with minimal mucinVimentin, desmin, CD34, estrogen and progesterone receptorNo recurrences reported, but rare cases of sarcomatous degeneration-
Superficial acral fibromyxomaPushing to infiltrativeMild to moderately accentuated vasculatureModerately cellular, spindle and stellate cells with a storiform to fascicular pattern, variable mast cellsMyxoid to collagenousCD34, EMA, CD99Recurrence rare and primarily for incompletely excised lesions-
Neurothekeoma Well circumscribed, multilobularHypovascularModerately cellular, spindled cells in fascicles and whorlsNests of cells separated by collagenous bundlesS-100, EMA47% if incompletely excised

1.SMA, smooth muscle actin. 2.MSA, muscle-specific actin. 3.EMA, epithelial membrane antigen.

Symptoms

Symptoms associated with cardiac myxomas are typically due to the effect of the mass of the tumor obstructing the normal flow of blood within the chambers of the heart. Because pedunculated myxomas are somewhat mobile, symptoms may only occur when the patient is in a particular position.
Some symptoms of myxoma may be associated with the release of interleukin 6 by the myxoma. High levels of IL-6 may be associated with a higher risk of embolism of the myxoma.
Symptoms of a cardiac myxoma include:

Ocular Myxoma

Myxoma is a rare, benign stromal tumor of mesenchymal origin often confused with other conjunctival stromal tumors. Conjunctival myxomas are thought to originate in Tenon's capsule and can masquerade as conjunctival lymphoma, lymphangioma, ocular surface squamous neoplasia, or amelanotic melanoma.

Atrial myxoma

Myxomas are usually located in either the left or right atrium of the heart; about 86 percent occur in the left atrium.
Myxomas are typically pedunculated, with a stalk that is attached to the interatrial septum. The most common location for attachment of the stalk is the fossa ovalis region of the interatrial septum.
An atrial myxoma may create an extra heart sound, audible to auscultation just after S2 It is most seen on echocardiography, as a pedunculated mass that is heterogeneous in appearance. A left atrial myxoma will cause an increase in pulmonary capillary wedge pressure.
The differential diagnosis include other cardiac tumors such as lipomas and rhabdomyomas. These other tumors of the heart are typically not pedunculated, however, and are more likely to infiltrate the muscle of the heart. Cardiac magnetic resonance imaging can help non-invasively diagnose cardiac tumors. However, diagnosis usually requires examination of a tissue sample by a pathologist.

Treatment

Myxomas are usually removed surgically. The surgeon removes the myxoma, along with at least 5 surrounding millimeters of atrial septum. The septum is then repaired, using material from the pericardium.

Epidemiology

Cardiac myxomas predominantly appear in females in their 30s to 40s. Myxomas are the most common primary cardiac tumor affecting adults, accounting for one quarter to half of primary cardiac tumors seen in clinical practice.